Delivery Order SPE2DB24D8002-SPE2DB25FJPDN
Award Date 7/22/25
Potential Completion Date 7/23/25
Potential Value $32K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $2,788.46 firm fixed-price delivery order is for the supply of Losartan-HCTZ 100-12.5 mg tablets in 90-count packages. The contract has an ultimate completion date of April 4, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense. The company holds a...
- This federal contract award, valued at $14,626.01, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a Firm Fixed Price Delivery Order for the delivery of 90-count bottles of Losartan-HCTZ 100-12.5 mg tablets. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, holding a significant single-award Indefinite Delivery Contract (IDC) valued at $999,999,999.00 for the provision of a...
- This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,807.32 firm fixed-price delivery order is for the supply of Losartan-HCTZ 100-12.5 mg tablets. This order is part of a larger $999,999,999.00 indefinite delivery contract (SPE2DB24D8001) held by Dakota Drug, Inc. under the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $8,439.71, is for the delivery of Losartan-HCTZ 100-12.5 mg tablets in 90-count packages. The contract has an ultimate completion date of March 6, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense through the DLA....
- This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) for the delivery of 4566854010 - LOSARTAN-HCTZ 100-25 MG TAB 90S. The contract has a ceiling value of $1,454.42 and a period of performance through January 8, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Losartan-HCTZ 100-25 mg tablets. The contract has a ceiling value of $1,747.92 and a completion date of February 11, 2025. The contract is a firm fixed-price delivery order, which is not associated with a set-aside program. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $18,462.43 firm fixed-price contract is for the delivery of 4566847986 LOSARTAN-HCTZ 100-25 MG TAB 90S to support U.S. Armed Forces medical operations. The contract has an ultimate completion date of January 7, 2025 and is not a set-aside. Dakota Drug, Inc. is also the prime contractor on a larger $999,999,999.00 Indefinite Delivery Contract...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, with a ceiling value of $5,037.52, is for the delivery of Losartan-HCTZ 100-12.5 mg tablets over the performance period ending on April 30, 2025. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $3,568.13 to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for the supply of Entresto 24 mg-26 mg tablets (60-count units). The contract is structured as a firm fixed price delivery order with an ultimate completion date of July 23, 2025, and was awarded on July 22, 2025. This award carries no set-aside designation, reflecting an unrestricted competitive procurement process. The delivery...
- Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation, has been awarded a firm fixed price delivery order totaling $4,633.34 by the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical) to supply 1,000 tablets of 25 mg Hydroxyzine HCl. The delivery order was issued against existing blanket purchase agreements with DLA Troop Support Medical to provide pharmaceuticals and medical supplies in support of military...